Scientific/Clinical ArticleSensitivity of the Patient-rated Forearm Evaluation Questionnaire in Lateral Epicondylitis
Section snippets
Subjects
We obtained approval from the Mayo Foundation Institutional Review Board before initiating this study, and each subject gave written informed consent for participation. Subjects were enrolled in a concurrent trial analyzing treatments for LE at a large multidisciplinary medical center.18 They received remuneration for participating in the collection of baseline data and in the six-week follow-up. Participation in the 12-week follow-up was optional because funding for remuneration at 12 weeks
Subjects
Of the 94 subjects included in the treatment trial, 44 were males (46.8%) and 50 were females (53.2%). Mean age (±SD) was 45.5 ± 7.7 years. Eighty-one subjects (86.2%) completed the study questionnaires at six weeks, and 49 (52.1%) completed them at 12 weeks. By six weeks, 13 subjects had dropped out of the study. There was no significant difference in age, sex, or baseline scores between the dropouts and the other study participants. As compared with subjects who completed the questionnaires at
Discussion
The PRFEQ appears to be a useful outcome tool in LE. As shown by Overend et al.4 and as supported by our data, it is highly reliable. We demonstrated reliability over consecutive days as well as after six weeks, adjusting for treatment. The PRFEQ also has an excellent SRM and effect size, indicating that it is sensitive to change.
There was a statistically significant correlation between the PRFEQ and the VAS, DASH, PFG, and bodily pain SF-36 subclass. However, the highest correlation was 0.74
Conclusions
The PRFEQ is reliable, reproducible, and sensitive in the assessment of LE. It is at least as sensitive to change as other commonly used outcome tools. Because the PRFEQ focuses on the elbow and forearm, whereas other instruments do not, we recommend that it be used as a standard outcome measure in LE research.
Quiz: Article #009
Record your answers on the Return Answer Form found at the back of this issue. There is only one best answer for each question.
- #1.
PRFEQ results were compared with:
- a.
DASH
- b.
VAS
- c.
SF-36
- d.
all of the above
- a.
- #2.
Lateral epicondylitis occurs in approximately ––––– of the population:
- a.
75%
- b.
25%
- c.
1–3%
- d.
5–10%
- a.
- #3.
Diagnostic inclusionary criteria were:
- a.
localized tenderness to the lateral epicondyl and pain to two of three provocative maneuvers
- b.
pain with isometric testing of the extensor carpi radialis brevis (only)
- c.
pain with isometric
- a.
References (21)
- et al.
Reliability of a patient-rated forearm evaluation questionnaire for patients with lateral epicondylitis
J Hand Ther
(1999) - et al.
Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial
Lancet
(2002)Aust J Physiother
(2002) - et al.
Comparative measurement sensitivity of short and longer health status instruments
Med Care
(1992) Prevalence, incidence, and remission rates of some common rheumatic diseases or syndromes
Scand J Rheumatol
(1974)- et al.
Lack of scientific evidence for the treatment of lateral epicondylitis of the elbow: an attempted meta-analysis
J Bone Joint Surg Br
(1992) - et al.
Effectiveness of physiotherapy for lateral epicondylitis: a systematic review
Ann Med
(2003) - et al.
Etiology, diagnosis, and treatment of tendonitis: an analysis of the literature
Med Sci Sports Exerc
(1998) - et al.
Randomized trial of oral naproxen or local injection of betamethasone in lateral epicondylitis of the humerus
Orthopedics
(1986) - et al.
Low-energy extracorporeal shock wave therapy for persistent tennis elbow
Int Orthop
(1996) - et al.
Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand). Corrected. The Upper Extremity Collaborative Group (UECG)
Am J Ind Med
(1996)
Cited by (67)
The patient-rated tennis elbow evaluation questionnaire was successfully translated to Korean
2022, Journal of Hand TherapyPhysical therapy for tendinopathy: An umbrella review of systematic reviews and meta-analyses
2020, Physical Therapy in SportCounterforce bracing of lateral epicondylitis: a prospective, randomized, double-blinded, placebo-controlled clinical trial
2019, Journal of Shoulder and Elbow Surgery